World Human Gene Sequencing Markets, Strategies, Trends, and Forecasts 2023-2027: Plummeting Costs for Genome Sequencing is Creating a Gold Rush with New Consumers, Market Niches and Technologies

DUBLIN, Feb. 29, 2024 /PRNewswire/ — The “Human Gene Sequencing Markets, Strategies & Trends – Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides – 2023 to 2027” report has been added to  ResearchAndMarkets.com’s offering.

Will all newborns receive genetic testing at birth? What segments are growing fastest? Where are the opportunities now that sequencing has gone mainstream?

The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out for five years. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

Scope of the Report

The Global Market for Human Genome Sequencing

Global Market Overview by CountryGlobal Market by Application – OverviewGlobal Market by Technology – OverviewGlobal Market by Workflow – OverviewGlobal Market by Product – Overview

Market Sizes by Application

Hereditary Gene Sequencing MarketNIPT Gene Sequencing MarketOncology MarketPsychology MarketWGES Gene Sequencing MarketPharmacogenomics MarketDTC Gene Sequencing MarketResearch Gene Sequencing MarketOther Application Market

Market Sizes by Technology

Sanger Sequencing MarketNGS/2G Market3G/Long MarketOther Technology Market

Market Sizes by Workflow

Sequencing MarketSample Prep MarketAnalysis Market

Market Sizes by Product

Instruments MarketConsumables MarketSoftware & Services Market

Vision of the Future of Human Gene Sequencing

Key Topics Covered:

1 Market Guides
1.1 Human Gene Sequencing Markets – Strategic Situation Analysis & COVID Impact
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition
2.1 Gene Sequencing Definition In This Report
2.1.1 Gene Sequencing
2.1.2 Hereditary
2.1.3 Non Invasive Prenatal Testing
2.1.4 Oncology
2.1.5 Psychology
2.1.6 WGES
2.1.7 Pharmacogenomic
2.1.8 Direct to Consumer
2.1.9 Research
2.1.10 Other
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
2.6.4 Genetic Testing vs. Gene Sequencing
2.6.5 Cost and Pricing Practice

3 Global Listing of Sequencer Installed Base – Location & Contacts
3.1 Notes to Installed Base Listing
3.2 Illumina Installed Base

4 Market Overview
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.5 Pathology Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.10 Audit Body
4.1.11 Certification Body
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease – Not what it used to be
4.2.1.1 Clinical and Research Lines Blur
4.2.1.2 Genetic Counselling – Not so simple anymore
4.2.1.3 The Genetic Blizzard – Issues of Access and Payment
4.2.2 Newborn Screening – The Standard of Care
4.2.2.1 Newborn Screening – Do Parents Want to Know?
4.2.3 NIPT – We’ve Only Just Begun
4.2.3.1 NIPT, IVF and the Fertility Practice – PGS, PGD, CCS
4.2.3.2 NIPT in the Future – Beyond Inherited Disease
4.2.4 Oncology – Understanding Two Worlds
4.2.4.1 The Tumor – A Sequence of Sequencing
4.2.4.2 The Tumor – Biopsy and Liquid Biopsy
4.2.4.3 The Human Genome – Predisposition and Prognosis
4.2.5 Pharmacogenomics
4.2.5.1 Sequencing Not the Only Player
4.2.5.2 New Roles for Old Drugs – A Research Bonanza?
4.2.6 Direct To Consumer – More Than Meets the Eye
4.2.6.1 DTC – How Many Segments?
4.3 Industry Structure
4.3.1 Hospital’s Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts – Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization

5 Market Trends
5.1 Factors Driving Growth
5.1.1 New Diagnoses
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer – Screening, Management and Monitoring
5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.2 Lower Costs
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
5.3.1 Instrumentation Tenacity
5.3.2 Declining Cost of Instruments Changes Industry Structure
5.3.3 Long Reads – Further Segmentation
5.3.4 Linked Reads
5.3.5 New Sequencing Technologies

6 Human Gene Sequencing Recent Developments
6.1 Recent Developments – Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Natera Files Suit Against NeoGenomics
6.3 Genomics England to Sequence 100K Newborns
6.4 Novigenix Raises $14M for NGS based Liquid Biopsy
6.5 LetsGetChecked Launching New PGx Service
6.6 Qiagen, Neuron23 Partner for NGS Diagnostic
6.7 Harbinger Health Technology Focused On Oncogenesis
6.8 Delfi Diagnostics to Develop Early Detection Test
6.9 Dante Labs to Introduce WGS to Italian Healthcare System
6.10 Invitae Neurodevelopmental Disorders Testing Service
6.11 Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
6.12 Myriad Genetics Launches Suite of Cancer Tests
6.13 Oncocyte and Thermo Fisher Strike Partnership Deal
6.14 Illumina Partners With Precision Medicine to Assess Liquid Biopsy
6.15 Sysmex Inostics Develops Ultra-Sensitive Liquid Biopsy
6.16 Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Testing
6.17 Strata Oncology Trial Supports NGS Assay
6.18 NYU Gets FDA Clearance for Sequencing Test
6.19 NeoGenomics to Acquire Inivata
6.20 OncoDNA, Institut Curie Partner on Liquid Biopsy Research
6.21 Cancer Heritability Gene Set Expanded
6.22 Whole-Genome Sequencing Could Replace Cytogenetics
6.23 Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays
6.24 Ancestry Shutters Health Offering
6.25 Genetron Health Targeting Early Cancer Detection
6.26 Pan-European Initiative to Build Tools for Sharing Genomic Data
6.27 UK Government Unveils New Genomic Healthcare Strategy
6.28 Foundation Medicine Liquid Biopsy Gets FDA Approval
6.29 American Heart Association Develops Genetic Testing Guidelines
6.30 Yourgene Health Gets CE Mark for Iona NIPT Test
6.31 NorthShore Looks to Expand Genomics Integration Into Primary Care
6.32 Germline Results From Tumor Sequencing Guides Precision Therapy
6.33 FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics
6.34 BillionToOne Closes $15M Series A Follow-on Round
6.35 Clinics to Integrate Genomics Into Primary Care

Appendices

United States Medicare System: January 2022 laboratory Fees ScheduleThe Whole Genome Sequence of SARS-CoV-2

Profiles of Key Companies

10x Genomics, Inc.23andME Inc.Abbott LaboratoriesAccuraGen Inc.Adaptive BiotechnologiesAdmera Health, LLCAgilent/DakoAkonni BiosystemsAmoy Diagnostics Co., Ltd.Ancestry.com LLCAnchor DxArc BioArrayit CorporationARUP LaboratoriesAstrid BioBaylor Miraca Genetics LaboratoriesBeckman Coulter DiagnosticsBecton, Dickinson and CompanyBGI Genomics Co. LtdBioarray GeneticsBiocept, Inc.Biodesix Inc.BioFluidicaBioGenexBiolidics LtdbioMerieux DiagnosticsBioneer CorporationBio-Rad Laboratories, Inc.Bio-TechneC2i GenomicsCaris Molecular DiagnosticsCellMax LifeCentogeneCepheid (Danaher)CirculogeneClinical GenomicsColor GenomicsComplete Genomics, Inc. – A BGI CompanyDante LabsDatar Cancer Genetics LimitedDiasorin S.p.A.Element BiosciencesEpic SciencesEpigenomics AGEurofins ScientificExcellerate BioscienceFabric GenomicsFreenomeFUJIFILM Wako DiagnosticsFujirebioFulgent GeneticsGE Global ResearchGene by Gene, Ltd.GenedriveGeneFirst Ltd.Genetron HoldingsGenewizGenomics EnglandGenomics Personalized Health (GPH)GenomOncologyGenzyme CorporationGrifolsGuardant HealthGuardiomeHeiScreenHelixHelomicsHologicHTG Molecular DiagnosticsHuman Longevity, Inc.iCellateIlluminaIncell DxInivataIntegrated DiagnosticsInvitae CorporationInvivoscribeKariusLetsgetcheckedLexageneLunglife AI IncMacrogenMDNA Life SCIENCES, Inc.MDx HealthMedgenomeMeridian BioscienceMesa Biotech (Thermo Fisher)Mesa Laboratories, Inc.miR ScientificMNG LabsNantHealth, Inc.NateraNebula Genomics 448NeoGenomicsNew England Biolabs, Inc.NGeneBioNovogene Bioinformatics Technology Co., Ltd.Omega BioservicesOncocyteOncoDNAOpGenORIG3N, Inc.Origene TechnologiesOxford Nanopore TechnologiesPanagenePerkin ElmerPersonal Genome DiagnosticsPersonalisPrecipioPrecisionMedPromegaProtagen DiagnosticsQiagenQuantuMDxRegeneron PharmaceuticalsRoche Molecular DiagnosticsRoswell BiotechnologiesSeegeneSeLux DiagnosticsSema4 HoldingsSequencing.comSiemens Healthineerssimfo GmbHSinglera Genomics Inc.Singular GenomicsSkylineDxStandard BioToolsSure Genomics, Inc.SysmexSysmex InosticsTempus Labs, Inc.Thermo Fisher Scientific Inc.Ultima GenomicsVariantyxVolitionVyant Bio

For more information about this report visit https://www.researchandmarkets.com/r/pc0g9v

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/world-human-gene-sequencing-markets-strategies-trends-and-forecasts-2023-2027-plummeting-costs-for-genome-sequencing-is-creating-a-gold-rush-with-new-consumers-market-niches-and-technologies-302075594.html

SOURCE Research and Markets